Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Catheter Precision Inc VTAK

Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide... see more

NYSEAM:VTAK - Post Discussion

Catheter Precision Inc > Catheter Precision Showcasing its Innovative 3D Mapping
View:
Post by averagepennies on Oct 10, 2023 8:42am

Catheter Precision Showcasing its Innovative 3D Mapping

VIVO to Be Highlighted at Several Electrophysiology Conferences

FORT MILL, SC / ACCESSWIRE / October 10, 2023 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK) announced that its innovative 3D Mapping system will be highlighted at several electrophysiology conferences this fall.

Most recently, VIVO was highlighted at the 19th Congresso Nazionale Associazione Italiana di Aritmologia e Cardiostimolazione in Bologna, Italy from September 21-22. Interim CEO David Jenkins remarked, "Our attendance not only highlighted our state-of-the-art technology but also cemented collaborations for evaluations at prominent VIVO sites, including Ospedale Della Misericordia Grosseto and Pisa CNR. VIVO received commendable feedback, recognizing its potential to revolutionize patient experience and EP lab efficiency."

Strengthening their foothold in Italy, Catheter Precision has strategically partnered with Precise S.r.l. "Our alliance with Precise S.r.l. is instrumental in solidifying our presence in the Italian medical landscape," Jenkins concluded.

In addition to VIVO, Catheter Precision will be present at other conferences also highlighting their newly introduced product, LockeT, a venous stasis closure device.

Future conferences that will highlight VIVO in the coming weeks are listed below.

  • Irish Cardiac Society's 74th Annual Scietific Meeting, October 12-14, 2023:
    • Presentation: "Testing the Validity of VIVO Technology: A Deep Dive into Ventricular Onset Mapping" by Professor Szeplaki's team from Mater Private Hospital, Dublin.
  • 18th Annual International Symposium on Ventricular Arrythmias, October 13-14, 2023
    • Location: Philadelphia, Pennsylvania
    • Spotlight: VIVO and LockeT products
  • 7th Annual Society of Cardiac RN Meeting, October 19-20, 2023:
    • Location: Washington, DC
    • Presentation: "3D Mapping for Robotic Ventricular Ablations Using VIVO" by Dr. Benjamin D'Souza from Penn Presbyterian Medical Center, Philadelphia, PA.
 

https://www.accesswire.com/791410/catheter-precision-showcasing-its-innovative-3d-mapping-system

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities